Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients
Clinical trial NCT01822340 · COMPLETED
Trial details
- NCT number
- NCT01822340
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2015-06-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.